[HTML][HTML] Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta …

J Truong, EK Lee, ME Trudeau, KKW Chan - Annals of Oncology, 2016 - Elsevier
Background Guidelines recommend primary prophylaxis (PP) with granulocyte-colony-
stimulating factors (G-CSF) for patients above a febrile neutropenia (FN) risk threshold of …

Primary G-CSF prophylaxis for adjuvant TC or FEC-D chemotherapy outside of clinical trial settings: a systematic review and meta-analysis

T Younis, D Rayson, K Thompson - Supportive Care in Cancer, 2012 - Springer
Background Variable febrile neutropenia (FN) rates reported with adjuvant TC (taxotere®,
cyclophosphamide) and FEC-D (5-flurouracil, epirubicin, cyclophosphamide, docetaxel) …

Low-intensity adjuvant chemotherapy for breast cancer in older women: results from the prospective multicenter HOPE trial

MS Sedrak, CL Sun, J Ji, HJ Cohen… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Older women with high-risk early breast cancer (EBC) benefit from adjuvant
chemotherapy, but their treatment is frequently complicated by toxic side effects, resulting in …

Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer

M Harvie, M Pegington, SJ Howell, N Bundred… - British Journal of …, 2022 - nature.com
Background Excess adiposity at diagnosis and weight gain during chemotherapy is
associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of …

Proof of concept of a mobile health short message service text message intervention that promotes adherence to oral anticancer agent medications: a randomized …

SL Spoelstra, CW Given, A Sikorskii… - Telemedicine and e …, 2016 - liebertpub.com
Introduction: This multisite, randomized controlled trial assigned 75 adult cancer patients
prescribed an oral anticancer agent to either an experimental group that received daily text …

[PDF][PDF] Feasibility of a text messaging intervention to promote self-management for patients prescribed oral anticancer agents

SL Spoelstra, CW Given, A Sikorskii… - Oncol Nurs …, 2015 - academia.edu
Purpose/Objectives: To determine proof of concept of a mobile health (mHealth) intervention
delivering text messages (texts) to self-manage among patients prescribed oral anticancer …

Quality of breast cancer treatment at a rural cancer center in Rwanda

DS O'Neil, NL Keating, JMV Dusengimana… - Journal of global …, 2017 - ascopubs.org
Purpose As breast cancer incidence and mortality rise in sub-Saharan Africa, it is critical to
identify strategies for delivery of high-quality breast cancer care in settings with limited …

Dose delays, dose reductions, and relative total dose intensity in patients with advanced cancer who exercised during neoadjuvant chemotherapy treatment

KY Wonders, K Schmitz… - Integrative Cancer …, 2023 - journals.sagepub.com
Background: When it comes to chemotherapy, maintaining the dose and schedule of
treatment are of vital importance, as clinical evidence suggests that dose intensity is …

Patterns of Anthracycline‐Based Chemotherapy‐Induced Adverse Drug Reactions and Their Impact on Relative Dose Intensity among Women with Breast Cancer in …

DA Gadisa, M Assefa, GM Tefera… - Journal of Oncology, 2020 - Wiley Online Library
Background. The breast cancer chemotherapy leads to diverse aspects of noxious or
unintended adverse drug reactions (ADRs) that cause the relative dose intensity (RDI) …

Young women with breast cancer: chemotherapy or surgery first? An evaluation of time to treatment for invasive breast cancer

E Guay, E Cordeiro, A Roberts - Annals of Surgical Oncology, 2022 - Springer
Background Breast cancer in young women (ages 18–40 years) is rare, yet remains a
leading cause of cancer-related death. Time to treatment (TTT) is an increasingly important …